175 related articles for article (PubMed ID: 16343658)
1. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
Scott AG; Tait A; Turner CM
Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ
Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084
[TBL] [Abstract][Full Text] [Related]
4. [Melarsoprol].
Simon F
Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
[No Abstract] [Full Text] [Related]
5. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
Pérez Martín O; Lastre González M; Urban M; Shwalbach J
Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism.
Fairlamb AH; Carter NS; Cunningham M; Smith K
Mol Biochem Parasitol; 1992 Jul; 53(1-2):213-22. PubMed ID: 1501641
[TBL] [Abstract][Full Text] [Related]
7. Effect of in vitro cultivation on the stability of resistance of Trypanosoma brucei brucei to diminazene, isometamidium, quinapyramine, and Mel B.
Kaminsky R; Zweygarth E
J Parasitol; 1989 Feb; 75(1):42-5. PubMed ID: 2918443
[TBL] [Abstract][Full Text] [Related]
8. Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
Carter NS; Fairlamb AH
Nature; 1993 Jan; 361(6408):173-6. PubMed ID: 8421523
[TBL] [Abstract][Full Text] [Related]
9. Investigations of the metabolites of the trypanocidal drug melarsoprol.
Keiser J; Ericsson O; Burri C
Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story.
Baker N; de Koning HP; Mäser P; Horn D
Trends Parasitol; 2013 Mar; 29(3):110-8. PubMed ID: 23375541
[TBL] [Abstract][Full Text] [Related]
11. [Action of drugs tested in an acellular medium and in mice infected with Trypanosoma brucei brucei].
Bouteille B; Darde ML; Pestre-Alexandre M
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):533-42. PubMed ID: 3143489
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
Poltera AA; Hochmann A; Lambert PH
Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
[TBL] [Abstract][Full Text] [Related]
13. The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol.
Jennings FW; Atouguia JM; Murray M
Acta Trop; 1996 Oct; 62(2):83-9. PubMed ID: 8988309
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for a link between melarsoprol resistance and P2 transporter function in African trypanosomes.
de Koning HP; MacLeod A; Barrett MP; Cover B; Jarvis SM
Mol Biochem Parasitol; 2000 Feb; 106(1):181-5. PubMed ID: 10743623
[No Abstract] [Full Text] [Related]
15. Arsenic and old taxa: subspeciation and drug sensitivity in Trypanosoma brucei.
Dukes P
Trans R Soc Trop Med Hyg; 1984; 78(6):711-25. PubMed ID: 6241967
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense.
Graf FE; Ludin P; Arquint C; Schmidt RS; Schaub N; Kunz Renggli C; Munday JC; Krezdorn J; Baker N; Horn D; Balmer O; Caccone A; de Koning HP; Mäser P
Cell Mol Life Sci; 2016 Sep; 73(17):3387-400. PubMed ID: 26973180
[TBL] [Abstract][Full Text] [Related]
17. Induction of resistance to melarsenoxide cysteamine (Mel Cy) in Trypanosoma brucei brucei.
Pospichal H; Brun R; Kaminsky R; Jenni L
Acta Trop; 1994 Dec; 58(3-4):187-97. PubMed ID: 7709858
[TBL] [Abstract][Full Text] [Related]
18. A nucleoside transporter from Trypanosoma brucei involved in drug resistance.
Mäser P; Sütterlin C; Kralli A; Kaminsky R
Science; 1999 Jul; 285(5425):242-4. PubMed ID: 10398598
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma brucei: effects of methoprene and other isoprenoid compounds on procyclic and bloodstream forms in vitro and in mice.
Harmon MA; Scott TC; Li Y; Boehm MF; Phillips MA; Mangelsdorf DJ
Exp Parasitol; 1997 Nov; 87(3):229-36. PubMed ID: 9371088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
